Co-Diagnostics PE Ratio 2017-2025 | CODX
Current and historical p/e ratio for Co-Diagnostics (CODX) from 2017 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Co-Diagnostics PE ratio as of July 17, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Co-Diagnostics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-17 | 0.28 | 0.00 | |
| 2025-03-31 | 0.31 | $-1.17 | 0.00 |
| 2024-12-31 | 0.75 | $-1.24 | 0.00 |
| 2024-09-30 | 1.25 | $-1.38 | 0.00 |
| 2024-06-30 | 1.25 | $-1.26 | 0.00 |
| 2024-03-31 | 1.12 | $-1.32 | 0.00 |
| 2023-12-31 | 1.33 | $-1.21 | 0.00 |
| 2023-09-30 | 1.06 | $-1.39 | 0.00 |
| 2023-06-30 | 1.11 | $-1.23 | 0.00 |
| 2023-03-31 | 1.48 | $-1.00 | 0.00 |
| 2022-12-31 | 2.52 | $-0.46 | 0.00 |
| 2022-09-30 | 3.21 | $0.47 | 6.83 |
| 2022-06-30 | 5.61 | $0.89 | 6.30 |
| 2022-03-31 | 6.18 | $1.30 | 4.75 |
| 2021-12-31 | 8.93 | $1.22 | 7.32 |
| 2021-09-30 | 9.73 | $1.40 | 6.95 |
| 2021-06-30 | 8.25 | $1.55 | 5.32 |
| 2021-03-31 | 9.54 | $1.65 | 5.78 |
| 2020-12-31 | 9.30 | $1.34 | 6.94 |
| 2020-09-30 | 13.59 | $0.81 | 16.78 |
| 2020-06-30 | 19.35 | $0.18 | 107.50 |
| 2020-03-31 | 7.62 | $-0.33 | 0.00 |
| 2019-12-31 | 0.90 | $-0.37 | 0.00 |
| 2019-09-30 | 1.03 | $-0.27 | 0.00 |
| 2019-06-30 | 0.80 | $-0.17 | 0.00 |
| 2019-03-31 | 1.06 | $-0.09 | 0.00 |
| 2018-12-31 | 1.49 | 0 | 0.00 |
| 2018-09-30 | 2.63 | 0 | 0.00 |
| 2018-06-30 | 3.88 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.009B | $0.004B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.339B | 25.95 |
| CVS Health (CVS) | United States | $80.708B | 10.03 |
| Elevance Health (ELV) | United States | $77.846B | 10.05 |
| Cencora (COR) | United States | $57.726B | 20.08 |
| DiDi Global (DIDIY) | China | $28.851B | 30.65 |
| Labcorp Holdings (LH) | United States | $20.589B | 16.70 |
| Natera (NTRA) | United States | $20.264B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $12.835B | 0.00 |
| Solventum (SOLV) | United States | $12.635B | 13.38 |
| ICON (ICLR) | Ireland | $11.632B | 10.81 |
| Revvity (RVTY) | United States | $11.186B | 19.25 |
| Viatris (VTRS) | United States | $10.657B | 3.66 |
| Medpace Holdings (MEDP) | United States | $9.049B | 24.03 |
| Sonic Healthcare (SKHHY) | Australia | $8.827B | 0.00 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.446B | 37.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.988B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.610B | 14.91 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.902B | 37.73 |
| Alignment Healthcare (ALHC) | United States | $2.649B | 0.00 |
| Concentras Parent (CON) | United States | $2.522B | 14.58 |
| Organon (OGN) | United States | $2.503B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.296B | 88.43 |
| Progyny (PGNY) | United States | $1.973B | 43.43 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Premier (PINC) | United States | $1.730B | 13.13 |
| Ardent Health (ARDT) | United States | $1.718B | 7.32 |
| GoodRx Holdings (GDRX) | United States | $1.700B | 34.00 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.263B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.101B | 8.38 |
| CareDx (CDNA) | United States | $1.069B | 16.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.754B | 7.06 |
| InnovAge Holding (INNV) | United States | $0.590B | 0.00 |
| Nutex Health (NUTX) | United States | $0.578B | 8.75 |
| Embecta (EMBC) | United States | $0.570B | 3.84 |
| SBC Medicals (SBC) | United States | $0.543B | 0.00 |
| So-Young (SY) | China | $0.530B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Omada Health (OMDA) | $0.476B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.368B | 0.00 |
| Enhabit (EHAB) | United States | $0.346B | 28.50 |
| Performant Healthcare (PHLT) | United States | $0.318B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.074B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |